In addition, the GEPIA database (http://gepia2.cancer-pku.cn/#analysis) indicated that patients with high NALT1 expression survived shorter than those with low NALT1 expression (Fig. 1E) and expression of NALT1 increased along with the stages of CRC progression (Fig. 1F). This evidence concerns the gene NALT1 and colorectal carcinoma.